Tilray (TLRY) Shares Down 8.9%
Tilray Inc (NASDAQ:TLRY)’s share price fell 8.9% during trading on Friday . The company traded as low as $97.00 and last traded at $109.05. 16,572,771 shares traded hands during mid-day trading, an increase of 119% from the average session volume of 7,572,819 shares. The stock had previously closed at $119.76.
Several equities research analysts have commented on the stock. Northland Securities downgraded shares of Tilray from an “outperform” rating to a “market perform” rating in a research note on Thursday, September 6th. Roth Capital downgraded shares of Tilray from a “buy” rating to a “neutral” rating in a research note on Wednesday, August 29th. They noted that the move was a valuation call. Finally, Cowen assumed coverage on shares of Tilray in a research note on Monday, August 13th. They issued an “outperform” rating and a $34.00 target price for the company.
Tilray (NASDAQ:TLRY) last issued its quarterly earnings data on Tuesday, August 28th. The company reported ($0.17) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.09) by ($0.08). The firm had revenue of $9.70 million for the quarter, compared to the consensus estimate of $9.01 million. The firm’s quarterly revenue was up 94.0% on a year-over-year basis. analysts expect that Tilray Inc will post -0.45 EPS for the current year.
Tilray Company Profile (NASDAQ:TLRY)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc was incorporated in 2018 and is headquartered in Nanaimo, Canada.
Further Reading: Understanding Relative Strength Index
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.